187 related articles for article (PubMed ID: 15748223)
1. When cure is care: diagnosis and management of pulmonary arterial hypertension.
Widmar B
J Am Acad Nurse Pract; 2005 Mar; 17(3):104-12. PubMed ID: 15748223
[TBL] [Abstract][Full Text] [Related]
2. Combination drug therapy in the management of pulmonary arterial hypertension.
Kayser SR
Prog Cardiovasc Nurs; 2005; 20(4):177-82. PubMed ID: 16276142
[No Abstract] [Full Text] [Related]
3. Clinical and cost-effectiveness of epoprostenol, iloprost, bosentan, sitaxentan and sildenafil for pulmonary arterial hypertension within their licensed indications: a systematic review and economic evaluation.
Chen YF; Jowett S; Barton P; Malottki K; Hyde C; Gibbs JS; Pepke-Zaba J; Fry-Smith A; Roberts J; Moore D
Health Technol Assess; 2009 Oct; 13(49):1-320. PubMed ID: 19863849
[TBL] [Abstract][Full Text] [Related]
4. Role of iloprost and bosentan in pulmonary arterial hypertension.
Saleh JA
Niger J Med; 2008; 17(1):13-9. PubMed ID: 18390125
[TBL] [Abstract][Full Text] [Related]
5. [Pulmonary hypertension: the issues of diagnosis and treatment].
Sakalauskas R; Barkauskiene D; Vebriene J; Sadauskas S
Medicina (Kaunas); 2004; 40(10):1019-25. PubMed ID: 15516828
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary hypertension: new perspectives.
Nauser TD; Stites SW
Congest Heart Fail; 2003; 9(3):155-62. PubMed ID: 12826774
[TBL] [Abstract][Full Text] [Related]
7. An evidence-based approach to the management of pulmonary arterial hypertension.
Archer SL; Michelakis ED
Curr Opin Cardiol; 2006 Jul; 21(4):385-92. PubMed ID: 16755209
[TBL] [Abstract][Full Text] [Related]
8. Treatment of pulmonary arterial hypertension.
Humbert M; Sitbon O; Simonneau G
N Engl J Med; 2004 Sep; 351(14):1425-36. PubMed ID: 15459304
[No Abstract] [Full Text] [Related]
9. Primary pulmonary hypertension.
Haworth SG
J R Coll Physicians Lond; 1998; 32(3):187-90. PubMed ID: 9670139
[No Abstract] [Full Text] [Related]
10. Idiopathic pulmonary arterial hypertension in children.
Rosenzweig EB; Barst RJ
Curr Opin Pediatr; 2005 Jun; 17(3):372-80. PubMed ID: 15891429
[TBL] [Abstract][Full Text] [Related]
11. [Therapeutic management of primary pulmonary hypertension].
Chaouat A; Weitzenblum E
Presse Med; 2002 Feb; 31(7):320-8. PubMed ID: 11899690
[TBL] [Abstract][Full Text] [Related]
12. Current treatment options in children with pulmonary arterial hypertension and experiences with oral bosentan.
Beghetti M
Eur J Clin Invest; 2006 Sep; 36 Suppl 3():16-24. PubMed ID: 16919006
[TBL] [Abstract][Full Text] [Related]
13. [Pulmonary arterial hypertension and systemic sclerosis].
Launay D; Humbert M; Hachulla E
Presse Med; 2006 Dec; 35(12 Pt 2):1929-37. PubMed ID: 17159719
[TBL] [Abstract][Full Text] [Related]
14. A new era in the treatment of primary pulmonary hypertension.
Bailey CL; Channick RN; Rubin LJ
Heart; 2001 Mar; 85(3):251-2. PubMed ID: 11179256
[No Abstract] [Full Text] [Related]
15. Bosentan improves exercise tolerance and Tei index in patients with pulmonary hypertension and prostanoid therapy.
Seyfarth HJ; Pankau H; Hammerschmidt S; Schauer J; Wirtz H; Winkler J
Chest; 2005 Aug; 128(2):709-13. PubMed ID: 16100158
[TBL] [Abstract][Full Text] [Related]
16. Survival of patients with idiopathic pulmonary arterial hypertension after listing for transplantation: impact of iloprost and bosentan treatment.
Dandel M; Lehmkuhl HB; Mulahasanovic S; Weng Y; Kemper D; Grauhan O; Knosalla C; Hetzer R
J Heart Lung Transplant; 2007 Sep; 26(9):898-906. PubMed ID: 17845928
[TBL] [Abstract][Full Text] [Related]
17. Diagnosing and treating primary pulmonary hypertension.
Frazier SK
Nurse Pract; 1999 Sep; 24(9):18, 21-2, 25-6 passim; quiz 42-3. PubMed ID: 10507069
[TBL] [Abstract][Full Text] [Related]
18. [Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to pulmonary fibrosis].
Olschewski H; Ghofrani HA; Walmrath D; Schermuly R; Temmesfeld-Wollbrück B; Grimminger F; Seeger W
Pneumologie; 2000 Mar; 54(3):133-42. PubMed ID: 10783653
[TBL] [Abstract][Full Text] [Related]
19. Role of Vasodilator Testing in Pulmonary Hypertension.
Sharma A; Obiagwu C; Mezue K; Garg A; Mukherjee D; Haythe J; Shetty V; Einstein AJ
Prog Cardiovasc Dis; 2016; 58(4):425-33. PubMed ID: 26434988
[TBL] [Abstract][Full Text] [Related]
20. "Treat-to-target" in pulmonary arterial hypertension and the use of extracorporeal membrane oxygenation as a bridge to transplantation.
Hoeper MM
Eur Respir Rev; 2011 Dec; 20(122):297-300. PubMed ID: 22130824
[No Abstract] [Full Text] [Related]
[Next] [New Search]
